SCHEMBL5263863

SCHEMBL5263863

COc1ccc(Cn2[nH]c(CBr)c(Br)c2=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CMA1 P23946 1/20 0.47
GSK3A P49840 1/20 0.45
GSK3B P49841 1/20 0.45
MAPT P10636 4/20 0.42
ALDH1A1 P00352 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
GAA P10253 1/20 0.42
MMP1 P03956 1/20 0.41
MMP13 P45452 1/20 0.41
DAO P14920 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
KDM4E B2RXH2 2/20 0.41
ALOX15 P16050 1/20 0.41
CXCR2 P25025 1/20 0.40
CASP3 P42574 1/20 0.40
NPBWR1 P48145 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5266153 0.86 CMA1 (0.47) CMA1GSK3AGSK3BMAPTALDH1A1
SCHEMBL16049899 0.77 CMA1 (0.47) CMA1GSK3AGSK3BMAPTALDH1A1
SCHEMBL11444891 0.72 CMA1 (0.49) CMA1GSK3AGSK3BMAPTALDH1A1
SCHEMBL16049922 0.71 CMA1 (0.47) CMA1GSK3AGSK3BMAPTALDH1A1
SCHEMBL31667227 0.71 MEN1 (0.61) MEN1KMT2ACASP3
SCHEMBL21092750 0.70 CMA1 (0.53) CMA1GSK3AGSK3BMAPTALDH1A1
SCHEMBL18717737 0.69 GSK3A (0.53) CMA1GSK3AGSK3BMAPTALDH1A1
SCHEMBL11618398 0.68 CMA1 (0.50) CMA1GSK3AGSK3BMAPTALDH1A1
SCHEMBL9376691 0.67 BRD4 (0.46) CMA1GSK3AGSK3BMAPTALDH1A1
SCHEMBL18732826 0.67 HTT (0.47) CMA1GSK3AGSK3BMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1833800-A1 PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS AstraZeneca AB (SE) 2007-09-19 EP disclosed
WO-2006071730-A1 PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS ASTRAZENECA AB (SE) 2006-07-06 WO disclosed